Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

OBR moving to ‘trust but verify’ relationship with Treasury after ‘black hole’ row – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

US economic growth slows, as Germany avoids recession and France gets Olympics boost – as it happened

Eurozone GDP grew by 0.4% in the last quarter, faster than expected, as Germany’s economy avoids second contraction in a row

The Guardian - UK

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

The Guardian - UK

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

Boris Johnson considered invading Holland to seize Covid vaccines

The then prime minister convened a meeting of senior military officials to discuss the plans.

Evening Standard

Boris Johnson: we considered ‘aquatic raid’ on Netherlands to seize Covid vaccine

Former prime minister admits in extract from forthcoming book that he discussed possible aquatic operation at height of pandemic

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

The Independent UK

First Self-Administered Flu Vaccine For Home Use Gets FDA Approval

FluMist nasal spray manufactured by AstraZeneca is now approved for home use against influenza infection caused by subtypes A and B from ages 2 through 49.

Medical Daily

FDA clears at-home nasal flu vaccine

AstraZeneca’s FluMist can now be taken at home

Salon

Businesses that try to come clean about their impact on nature can end up concealing more than they reveal

Humans have overfished the ocean, cleared forests, polluted water and created a climate crisis by burning fossil fuels. These actions are affecting biodiversity around the world, from remote islands to our own backyards.

The Conversation

Fortune LGBTQ+ Leaders

What will the LGBTQ+ Leaders of the future look like? Here are some of the names we expect to see a lot more of in the coming years.

Fortune

Man, 27, dies weeks after receiving Covid vaccine he was wrongly invited to take by NHS

Jack Last died after having the AstraZeneca Covid jab following a ‘litany’ of errors by GP services and the NHS

The Independent UK

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

China detains five AstraZeneca staff over ‘data privacy and import breaches’

Detentions involve Chinese citizens who marketed cancer drugs for firm’s oncology division

The Guardian - UK

Britain could be a sci-tech superpower – if the Treasury stopped holding it back

The UK has the research base, the startups, the venture capitalists, but its presence in the global market is pitiful. The chancellor must step in

International Business Times

Big Pharma Push Back On First Medicare Drug Price Cuts

Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent.

Salon

Big Pharma fought to keep prices high

Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

As Radiotherapy Redefines Cancer Care, Here's the Stock to Buy Near 52-Week Highs

A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional" cancers that make the disease the leading cause of death worldwide, which is why Morgan Stanley forecast the radiopharma…

The Guardian - UK

Reeves should nail down UK AstraZeneca deal. A collapse would be embarrassing

Chancellor hopes to cut state aid for Speke vaccine plant to £40m. But pro-growth Treasury must not let project slip overseas

The Guardian - UK

Blow to AstraZeneca vaccine project as Reeves plans funding cuts

Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant

The Guardian - UK

The Guardian view on record payouts for CEOs: the way they live now

Editorial: The latest High Pay Centre report confirms the persistent and damaging culture of entitlement at the top of business

Fortune

Typical FTSE 100 CEO pay hits record high of £4.2 million—but U.S. peers still earn 3 times as much

AstraZeneca’s Pascal Soriot and Rolls Royce’s Tufan Erginbilgic were among the highest-paid FTSE 100 CEOs, but what they make still trails behind the average pay of S&P 500 CEOs.

The Guardian - UK

FTSE 100 chief executive pay reaches highest level on record

Bosses of UK’s biggest companies are now paid 120 times more than average full-time worker in some instances

The Times of India

AstraZeneca's breast cancer drug fails in late-stage trial test

Truqap, the breast cancer drug which was on trial has failed to meet its main goal, the drug manufacturer AstraZeneca said on Tuesday. It said that its breast cancer drug, Truqap, in combination with chemotherapy agent, paclitaxel, did not meet its main goals in a late-stage trial to improve overall…

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.